CCAP's fundamental outlook appears increasingly strained: net interest income collapsed from $31.5M in 2024Q1 to a deficit of -$14.9M in 2026Q2, inverting net interest margin to -0.9% and driving consecutive quarterly losses of -$15.5M and -$3.2M.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 10, 2026 | $0.36-2.6% vs $0.37 | $36M-2.1% vs $37M |
Q2 2026 May 13, 2026 | $0.42+2.4% vs $0.41 | $38M-4.2% vs $40M |
Q1 2026 Feb 25, 2026 | $0.45+2.3% vs $0.44 | $41M+1.8% vs $40M |
Q4 2025 Nov 12, 2025 | $0.46-0.4% vs $0.46 | $41M-2.4% vs $42M |
A lender, a mortgage insurer, a Pennsylvania bank, and a Montana utility all pay dividends that earnings cover. But one of them just cut its payout, and its price tag tells you how nervous investors have become.
The BDC sector trades at historically wide discounts, offering a 3.25% yield pickup versus NAV and significant margin of safety. Current sector discounts imply extreme default rates, unsupported by historical loss data or recent credit performance, suggesting discounts are overly pessimistic. Rising Fed Funds rates are set to boost BDC net investment income by around 8%, supporting dividend coverage and potential increases for well-positioned names.
LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP, one of the leading alternative credit investment firms, today announced the pricing of Atlas Senior Loan Fund XXVIII (“Atlas 28”), a $406.9 million new-issue collateralized loan obligation (“CLO”) on October 29, 2026. This transaction represents Crescent's second new-issue CLO of 2026 and the fourth issued through its CLO Equity Fund II, which closed in August. The transaction attracted 20 distinct investors, and will invest primarily in.
LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the third quarter ended September 30, 2026 on Monday, November 9, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Tuesday, November 10, 2026 at 12:00 p.m. Eastern Time to discuss its third quarter ended September 30, 2026 financial results.
Benchmark CCAP against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Crescent Capital BDC, Inc. (CCAP)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $9.38 | $345.62M | -109.07 | 87.04% | -4.46% | -0.46% | 19.52% | |
| $19.13 | $13.74B | 15.74 | -11.83% | 55% | 6.23% | 9.45% | |
| $12.74 | $3.32B | 22.62 | 44.68% | 31.97% | 3.82% | 10.87% | |
| $10.26 | $845.14M | -11.49 | 148.55% | -62.33% | -6.33% | 14.8% | |
| $4.37 | $177.42M | 8.17 | 55.25% | 58.87% | 6.24% | 23.45% | |
| $6.88 | $682.62M | 13.58 | -27.91% | 66.56% | 4.82% | 17.52% |
Crescent Capital BDC, Inc. (CCAP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Crescent Capital BDC, Inc. (CCAP) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 10, 2026·SEC
Jul 1, 2026·SEC
Jun 24, 2026·SEC
Get notified when CCAP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Crescent Capital BDC, Inc. (CCAP) stock FAQ — growth, dividends, profitability & financials explained
Crescent Capital BDC, Inc. (CCAP) grew revenue by 25.2% over the trailing twelve months, compared with the twelve months before.
No. Crescent Capital BDC, Inc. (CCAP) reported a net loss of $3.2M over the trailing twelve months.
Yes. Crescent Capital BDC, Inc. (CCAP) pays a dividend that yields 19.52% at the current price, a high yield.
Crescent Capital BDC, Inc. (CCAP) had a return on equity (ROE) of -0.5% over the trailing twelve months. A negative ROE means the company lost money over the period.
Crescent Capital BDC, Inc. (CCAP) has a net interest margin (NIM) of 8811.5%. This indicates healthy earnings from lending activities.
Crescent Capital BDC, Inc. (CCAP) has an efficiency ratio of 1.9%. This is excellent, indicating strong cost control.
